Recombinant DNA: The First Report

Credit: COURTESY OF TERRY SHARRER" /> Credit: COURTESY OF TERRY SHARRER In a series of experiments in the late 1960s and early 1970s, Stanley Cohen, Herbert Boyer, and their colleagues developed the techniques necessary to recombine genes in bacterial plasmids, allowing for their mass production and launching recombinant biotechnology as we know it. In 1973, the Cohen-Boyer team introduced a plasmid fragment from one strain of Escherichia coli, conferring kanamycin resistance in

Written byTerry Sharrer
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In a series of experiments in the late 1960s and early 1970s, Stanley Cohen, Herbert Boyer, and their colleagues developed the techniques necessary to recombine genes in bacterial plasmids, allowing for their mass production and launching recombinant biotechnology as we know it.

In 1973, the Cohen-Boyer team introduced a plasmid fragment from one strain of Escherichia coli, conferring kanamycin resistance into another E. coli plasmid for tetracycline resistance, and then inserted the recombined DNA into live E. coli cells, which showed both characteristics.1 In 1974, they crossed species barriers, joining DNA fragments from Staphylococcus aureus, for ampicillin resistance, with the tetracycline resistance plasmid, and then cloned it into E. coli.2 Next they crossed kingdom barriers, inserting eukaryotic DNA - it was a ribosome gene from the African clawed frog, Xenopus laevis - into E. coli.3

The bacteria not only mass-produced these "molecular chimeras," but they also transcribed the gene, demonstrating ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026, Issue 1

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs
Graphic of three DNA helices in various colors

An Automated DNA-to-Data Framework for Production-Scale Sequencing

illumina
Exploring Cellular Organization with Spatial Proteomics

Exploring Cellular Organization with Spatial Proteomics

Abstract illustration of spheres with multiple layers, representing endoderm, ectoderm, and mesoderm derived organoids

Organoid Origins and How to Grow Them

Thermo Fisher Logo

Products

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control

Biotium Logo

Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging

Colorful abstract spiral dot pattern on a black background

Thermo Scientific X and S Series General Purpose Centrifuges

Thermo Fisher Logo
Abstract background with red and blue laser lights

VANTAstar Flexible microplate reader with simplified workflows

BMG LABTECH